Drug Trial Radar · NCT06793215
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Last checked: Nov 19, 2026Latest source record: Nov 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
600
Planned (sponsor's estimate)
Start
Oct 24, 2025
Primary completion
Nov 30, 2028
Study completion Oct 31, 2030
Sponsor
- Lead sponsor
- Hoffmann-La RocheRoche (Genentech) (RHHBY)
- Sponsor type
- Industry
- Collaborators
- Chugai Pharmaceutical
- First posted
- Jan 27, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the efficacy and safety of divarasib and pembrolizumab compared with pembrolizumab and pemetrexed and carboplatin or cisplatin, for the first-line treatment of adult participants with KRAS G12C-mutated, advanced or metastatic non squamous non-small cell lung cancer (NSCLC).
Conditions
- Non-Small Cell Lung Cancer
- KRAS G12C Lung Cancer
Interventions
DivarasibDrug
Divarasib will be administered orally QD
PembrolizumabDrug
Pembrolizumab will be administered via IV infusion Q3W
PemetrexedDrug
Pemetrexed will be administered via IV infusion Q3W
CarboplatinDrug
Carboplatin will be administered via IV infusion Q3W
CisplatinDrug
Cisplatin will be administered via IV infusion Q3W
Primary outcomes
What the sponsor says the trial is designed to measure.
- Progression-Free Survival (PFS)Time frame: Up to approximately 5 years
- Overall Survival (OS)Time frame: Up to approximately 5 years
Locations
299 sites in 28 countries. Site status is shown where the registry gives one.
Alaska Oncology and Hematology
Anchorage, Alaska · Recruiting
City of Hope - Phoenix
Goodyear, Arizona · Recruiting
Community Cancer Institute (CCI)
Clovis, California · Recruiting
Marin Cancer Care Inc
Greenbrae, California · Recruiting
UCI Health-CIACC
Irvine, California · Recruiting
UCLA Oncology Center
Los Angeles, California · Recruiting
Hoag Memorial Hospital
Newport Beach, California · Recruiting
University of California Irvine
Orange, California · Recruiting
Palo Alto Medical Foundation Research Center
Palo Alto, California · Recruiting
Sutter Institute for Medical Research
Roseville, California · Recruiting
California Pacific Medical Center
San Francisco, California · Recruiting
UC Health Oncology Research
Colorado Springs, Colorado · Recruiting
Poudre Valley Health Care, Inc. d/b/a Poudre Valley Health System
Fort Collins, Colorado · Recruiting
Grand Valley Oncology
Grand Junction, Colorado · Recruiting
Hartford Hospital
Hartford, Connecticut · Recruiting
Florida Cancer Specialists - SOUTH - SCRI - PPDS
Fort Myers, Florida · Recruiting
University of Florida Health at Shands
Gainesville, Florida · Recruiting
BioResearch Partner
Hialeah, Florida · Recruiting
Memorial Healthcare System - Memorial Regional Hospital
Hollywood, Florida · Recruiting
Sylvester Comprehensive Cancer Center
Miami, Florida · Recruiting
Advent Health Orlando
Orlando, Florida · Recruiting
Ascension Sacred Heart
Pensacola, Florida · Recruiting
Florida Cancer Specialists - NORTH - SCRI - PPDS
St. Petersburg, Florida · Recruiting
Florida Cancer Specialists - EAST - SCRI - PPDS
West Palm Beach, Florida · Recruiting
Piedmont Cancer Institute, PC
Atlanta, Georgia · Recruiting
City of Hope® Atlanta
Newnan, Georgia · Recruiting
Summit Cancer Care PC
Savannah, Georgia · Recruiting
St. Luke's Cancer Institute
Boise, Idaho · Recruiting
Affiliated Oncologists, LLC
Chicago Ridge, Illinois · Recruiting
Hope and Healing Cancer Services
Hinsdale, Illinois · Withdrawn
City of Hope® Cancer Center Chicago
Zion, Illinois · Recruiting
Mission Cancer + Blood - IMMC
Des Moines, Iowa · Recruiting
University of Iowa
Iowa City, Iowa · Recruiting
Saint Agnes Hospital - Baltimore - Hunt - PPDS
Baltimore, Maryland · Recruiting
Walter Reed National Military Medical Center
Bethesda, Maryland · Recruiting
Massachusetts General Hospital
Boston, Massachusetts · Recruiting
University of Massachusetts Memorial Medical Center
Worcester, Massachusetts · Recruiting
Profound Research, LLC
Farmington Hills, Michigan · Recruiting
Metro-Minnesota Community Oncology Research Consortium
Saint Louis Park, Minnesota · Recruiting
University of Mississippi Medical Center
Jackson, Mississippi · Recruiting
Showing 40 of 299 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.